KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Change in Inventory (2016 - 2025)

Bausch Health Companies (BHC) has disclosed Change in Inventory for 17 consecutive years, with $5.0 million as the latest value for Q4 2025.

  • Quarterly Change in Inventory fell 89.8% to $5.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $12.0 million through Dec 2025, down 95.51% year-over-year, with the annual reading at $12.0 million for FY2025, 95.51% down from the prior year.
  • Change in Inventory hit $5.0 million in Q4 2025 for Bausch Health Companies, up from -$16.0 million in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $144.0 million in Q1 2024 to a low of -$46.0 million in Q4 2021.
  • Historically, Change in Inventory has averaged $40.8 million across 5 years, with a median of $33.5 million in 2021.
  • Biggest five-year swings in Change in Inventory: soared 2400.0% in 2023 and later tumbled 138.1% in 2025.
  • Year by year, Change in Inventory stood at -$46.0 million in 2021, then soared by 108.7% to $4.0 million in 2022, then skyrocketed by 2400.0% to $100.0 million in 2023, then tumbled by 51.0% to $49.0 million in 2024, then crashed by 89.8% to $5.0 million in 2025.
  • Business Quant data shows Change in Inventory for BHC at $5.0 million in Q4 2025, -$16.0 million in Q3 2025, and -$7.0 million in Q2 2025.